Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients

NCT06929507 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Renal Function Disorder
Diabetic Macular Edema (DME)
Neovascular Age Related Macular Degeneration

Interventions

DRUG: Intravitreal injection of Faricimab or Aflibercept 2 mg

Sponsor

University Hospital, Alexandroupolis